14M128: Plenary III

Abstract Moderator(s)

• 

  Anne Davidson, MBBS, FRACP

  Feinstein Institutes for Medical Research
  Manhasset, NY, United States

  Disclosure(s): Alpine Immune Sciences: Officer or Board Member (Ongoing); Viela Bio: Consultant (Ongoing)
• 

  Zsuzsanna McMahan, MD, MHS

  Johns Hopkins Rheumatology
  Lutherville, MD, United States

  Disclosure(s): Cumberland: I help with skin biopsies for a clinical trial at Hopkins (Ongoing); Horizon: I was going to be a sub-I but did not do it as I was interested in helping with the ACR ILD Guideline Development (Terminated); Kadmon: I help with skin biopsies for a clinical trial at Hopkins (Ongoing); Mitsubishi: I help with skin biopsies for a clinical trial at Hopkins (Ongoing)

Plenary abstract session.

Presentations:

• 11:30 AM – 11:40 AM Eastern Time

  Effectiveness of Intensive Diet and Exercise on Knee Pain Among Communities with Knee Osteoarthritis, Overweight, and Obesity: The WE-CAN Pragmatic Randomized Clinical Trial
  

  Presenting Author: Stephen Messier, PhD – Wake Forest University
• 11:40 AM – 11:45 AM Eastern Time

  Q&A
  
• 11:45 AM – 11:55 AM Eastern Time

  Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multicenter, Randomized, Double Blind, Placebo Controlled Trial (SAPHYR)
  

  Presenting Author: Robert Spiera, MD – Hosptial for Special Surgery
• 11:55 AM – 12:00 PM Eastern Time

  Q&A
  
• 12:00 PM – 12:10 PM Eastern Time

  Chimeric Autoantigen-T Cell Receptor (CATCR)-T Cell Therapies to Selectively Target Autoreactive B Cells
  

  Presenting Author: Maximilian F. Konig, MD – The Johns Hopkins University School of Medicine
• 12:10 PM – 12:15 PM Eastern Time

  Q&A
  
• 12:15 PM – 12:25 PM Eastern Time

  A Genome-Wide Association Analysis of 2,622,830 Individuals Reveals New Pathogenic Pathways in Gout
  

  Presenting Author: Tony Merriman, PhD – University of Alabama at Birmingham
• 12:25 PM – 12:30 PM Eastern Time

  Q&A
  
• 12:30 PM – 12:40 PM Eastern Time

  The Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA (STOP-JIA) Study: Three-Year Outcomes
  

  Presenting Author: Yukiko Kimura, MD – Hackensack Meridian School of Medicine
• 12:40 PM – 12:45 PM Eastern Time

  Q&A
  
• 12:45 PM – 12:55 PM Eastern Time

  Module Signatures of Synovial Single-cell States Identify Disease Phenotypes in Early Treatment-naive Rheumatoid Arthritis
  

  Presenting Author: Felice Rivellese, MD, PhD – Queen Mary University of London
• 12:55 PM – 1:00 PM Eastern Time

  Q&A